Matthias Wulf

Matthias Wulf

Matthias is a Principal at the BioInnovation Institute in Copenhagen where he anchors several therapeutics and women’s health companies. Prior to joining BII, Matthias worked as an investment analyst at the corporate VC, M Ventures, in Amsterdam, as a pharmacist...
Preben Bruun-Nyzell

Preben Bruun-Nyzell

Preben is 2N Pharma’s co-founder and CEO and brings broad business and finance experience from an international career spanning nine countries over 25 years. He is co-founder of clinical-stage vaccine company 2A Pharma, and chairman...
John Nieland, PhD

John Nieland, PhD

John is 2N Pharma’s co-founder and CSO and brings broad management experience and in-depth research background. He was previously director of research at Medigene AG and is co-founder of the clinical-stage vaccine company 2A Pharma and two other biotech...